AI Verdict
HUBB has stronger fundamentals based on our AI analysis.
HUMAW vs HUBB Fundamental Comparison
| Metric | HUMAW | HUBB |
|---|---|---|
| Revenue | $2.0M | $5.8B |
| Net Income | $-40.8M | $887.1M |
| Net Margin | -2,003.6% | 15.2% |
| ROE | -1,313.4% | 23.1% |
| ROA | -35.1% | 10.8% |
| Current Ratio | 3.69x | 1.72x |
| Debt/Equity | 11.40x | 0.53x |
| EPS | $-0.26 | $16.54 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HUMAW vs HUBB: Frequently Asked Questions
Is HUMAW or HUBB a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HUBB has stronger fundamentals. HUMAW is rated STRONG SELL (88% confidence) while HUBB is rated BUY (78% confidence). This is not investment advice.
How does HUMAW compare to HUBB fundamentally?
Humacyte, Inc. has ROE of -1,313.4% vs HUBBELL INC's 23.1%. Net margins are -2,003.6% vs 15.2% respectively.
Which stock pays higher dividends, HUMAW or HUBB?
HUMAW has a dividend yield of N/A or no dividend while HUBB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HUMAW or HUBB for long term?
For long-term investing, consider that HUMAW has STRONG SELL rating with 88% confidence, while HUBB has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HUMAW vs HUBB?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HUMAW vs HUBB, the AI consensus favors HUBB based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.